Targeting the DNA damage response and repair in cancer through nucleotide metabolism
Open Access
- 28 May 2022
- journal article
- review article
- Published by Wiley in Molecular Oncology
- Vol. 16 (21) , 3792-3810
Abstract
The exploitation of the DNA damage response and DNA repair proficiency of cancer cells is an important anticancer strategy. The replication and repair of DNA are dependent upon the supply of deoxynucleoside triphosphate (dNTP) building blocks, which are produced and maintained by nucleotide metabolic pathways. Enzymes within these pathways can be promising targets to selectively induce toxic DNA lesions in cancer cells. These same pathways also activate antimetabolites, an important group of chemotherapies that disrupt both nucleotide and DNA metabolism to induce DNA damage in cancer cells. Thus, dNTP metabolic enzymes can also be targeted to refine the use of these chemotherapeutics, many of which remain standard of care in common cancers. In this review article, we will discuss both these approaches exemplified by the enzymes MTH1, MTHFD2 and SAMHD1. © 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.Keywords
Funding Information
- Barncancerfonden (PR2019‐0014, PR2021‐0030)
- Cancerfonden (19‐0056‐JIA, 20‐0879‐Pj, 21‐1490‐Pj)
- Dr Åke Olssons Stiftelse för Haematologisk Forskning (2022‐00304)
- Karolinska Institutet
- Novo Nordisk Fonden (NNF19SA0059297)
- Sjöbergstiftelsen
- Vetenskapsrådet (2015‐00162, 2018‐02114, 2021‐03094, 2021‐06383)
This publication has 148 references indexed in Scilit:
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- hMTH1 expression protects mitochondria from Huntington's disease-like impairmentNeurobiology of Disease, 2013
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 proteinNature, 2011
- SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by VpxNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Edgetic perturbation models of human inherited disordersMolecular Systems Biology, 2009
- Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiaeProceedings of the National Academy of Sciences, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006